Lb Research
Lb Research is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Safety of ELGN-2112 in Populations of Interest
Sponsor Elgan Pharma Ltd.
- Start (EU)
- Latest update
- Estimated end
A Multi-Center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Sponsor Elgan Pharma Ltd.
- Start (EU)
- Latest update
- Estimated end
A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain
Sponsor Fidia Farmaceutici S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, double-blind, parallel-groups, active - and placebo-controlled study to Evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injection, in reLIEving back pain symptoms. Controlled study vs. dicloFenac 75 mg solution for injection and placebo. RELIEF Study
Sponsor Epifarma S.r.l.
- Start (EU)
- Latest update
- Estimated end
- Not reported
RESTORING SENSITIVITY TO IMMUNOTHERAPY IN ADVANCED TRIPLE NEGATIVE BREAST CANCER EXPLOITING CERALASERTIB PRIMING FOLLOWED BY COMBINED DURVALUMAB/NAB-PACLITAXEL: THE ATRiBRAVE TRIAL
Sponsor IFOM Istituto Fondazione Di Oncologia Molecolare Ets In Breve Ifom Ets
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, multi-center, double-blind, two-armed, parallel active groups, prospective trial, to evaluate, in pediatric population undergoing 'Calcaneo stop' surgery or Inguinal hernia repair, the efficacy and safety of chloroprocaine 1% and 2% for peripheral nerve block based on concentration-response relationships.
Sponsor Sintetica S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, double-blind, placebo-controlled, multicenter clinical trial to assess safety and effectiveness of Liposom in enhance and speed up response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD)
Sponsor Fidia Farmaceutici S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Lb Research?
The 2026-10-09 snapshot links Lb Research to 7 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Electronic data capture, Medical writing, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Lb Research?
The most frequently recorded therapeutic areas are Gastroenterology, Nutrition. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Lb Research conducted?
The linked trials record locations in 7 countries, including Italy, Austria, Spain, France, Netherlands. These are trial locations, not confirmed office locations or countries where Lb Research delivered services.
What can this page tell me about Lb Research's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Lb Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Lb Research S.r.l.